We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $542M
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$627M
AUM Growth
+$293M
Cap. Flow
+$262M
Cap. Flow %
41.75%
Top 10 Hldgs %
78.72%
Holding
74
New
18
Increased
16
Reduced
19
Closed
12

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$18.2M
2
DNA icon
Ginkgo Bioworks
DNA
+$7.31M
3
MU icon
Micron Technology
MU
+$6.43M
4
PYPL icon
PayPal
PYPL
+$6.04M
5
BIDU icon
Baidu
BIDU
+$4.27M

Top Sells

Rank Stock Value
1
AA icon
Alcoa
AA
+$18.1M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$15.4M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$13.7M
4
PAAS icon
Pan American Silver
PAAS
+$7.19M
5
NKTR icon
Nektar Therapeutics
NKTR
+$5.15M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Materials 9.66%
3 Technology 4.11%
4 Communication Services 2.12%
5 Financials 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRI icon
26
Capri Holdings
CPRI
$1.82B
$2.98M 0.47%
+90,000
New +$3.26M
ZYME icon
27
Zymeworks
ZYME
$1.69B
$2.86M 0.46%
336,344
+43,844
+15% +$390K
NKTR icon
28
Nektar Therapeutics
NKTR
$2.41B
$2.69M 0.43%
144,429
-244,342
-63% -$5.15M
GOSS icon
29
Gossamer Bio
GOSS
$97.5M
$2.46M 0.39%
2,726,104
+2,170,104
+390% +$1.62M
PSLV icon
30
Sprott Physical Silver Trust
PSLV
$12B
$2.28M 0.36%
230,000
– –
BTG icon
31
B2Gold
BTG
$5.16B
$2.16M 0.34%
800,000
+182,815
+30% +$494K
ORIC icon
32
Oric Pharmaceuticals
ORIC
$1.24B
$2.13M 0.34%
301,650
+171,650
+132% +$1.54M
AAPL icon
33
PUT
Apple
AAPL
$4.95T
$2.11M 0.34%
10,000
– –
MSOS icon
34
AdvisorShares Pure US Cannabis ETF
MSOS
$860M
$1.85M 0.3%
252,712
-114,788
-31% -$1M
NBIS
35
Nebius Group N.V.
NBIS
$47.7B
$1.56M 0.25%
105,000
– –
PRGO icon
36
Perrigo
PRGO
$1.4B
$1.54M 0.25%
+60,000
New +$1.76M
CIEN icon
37
Ciena
CIEN
$53.4B
$1.45M 0.23%
30,000
+12,500
+71% +$593K
MRVI icon
38
Maravai LifeSciences
MRVI
$987M
$1.43M 0.23%
200,000
+41,849
+26% +$361K
MREO
39
Mereo BioPharma
MREO
$48.2M
$1.25M 0.2%
348,128
-56,872
-14% -$184K
TDOC icon
40
Teladoc Health
TDOC
$1.61B
$1.22M 0.19%
+125,000
New +$1.52M
VNDA icon
41
Vanda Pharmaceuticals
VNDA
$314M
$1.09M 0.17%
+192,926
New +$996K
NVAX icon
42
Novavax
NVAX
$1.23B
$1.08M 0.17%
85,000
-103,900
-55% -$1.05M
QDEL icon
43
QuidelOrtho
QDEL
$1.15B
$1.04M 0.17%
+31,253
New +$1.28M
FET icon
44
Forum Energy Technologies
FET
$640M
$1M 0.16%
59,604
– –
SOL
45
DELISTED
Emeren Group
SOL
$972K 0.15%
647,745
-522,255
-45% -$957K
MAG
46
DELISTED
MAG Silver
MAG
$959K 0.15%
82,200
– –
FATE icon
47
Fate Therapeutics
FATE
$283M
$941K 0.15%
286,900
-29,905
-9% -$131K
PARA
48
DELISTED
Paramount Global Class B
PARA
$883K 0.14%
85,000
-45,000
-35% -$527K
XPER icon
49
Xperi
XPER
$367M
$859K 0.14%
+104,660
New +$989K
NGD
50
DELISTED
New Gold Inc
NGD
$858K 0.14%
440,000
+35,000
+9% +$66.5K
1
2
3

Similar funds

BCB
Brian C. Broderick $542M AUM 20.28% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Monaco Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monaco Asset Management held 74 positions worth $627M, up 88% from $334M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Monaco Asset Management deployed $262M of net new capital in Q2 2024, opening 18 new positions and adding to 16 existing holdings. Its largest new stake was Ginkgo Bioworks: 245,000 shares worth $3.28M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 22% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Alcoa, an estimated $18.1M trimmed.

  • Monaco Asset Management's largest Q2 2024 buy was Ginkgo Bioworks: 245,000 shares worth $3.28M.
  • Monaco Asset Management added most to Newmont in Q2 2024, an estimated $18.2M increase.
  • Monaco Asset Management's biggest Q2 2024 reduction was Alcoa, cutting an estimated $18.1M.
  • Monaco Asset Management fully exited Alibaba in Q2 2024, selling an estimated $4.7M.
  • Monaco Asset Management's ten largest holdings make up 79% of its $627M portfolio in Q2 2024.
  • Monaco Asset Management opened 18 new positions and closed 12 in Q2 2024.
  • Monaco Asset Management's portfolio value rose 88% quarter-over-quarter to $627M.

Based on Monaco Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.